DK1358159T3 - 3,4-diaminopyridintartrat og phosphat, farmaceutiske præparater og anvendelser deraf - Google Patents
3,4-diaminopyridintartrat og phosphat, farmaceutiske præparater og anvendelser derafInfo
- Publication number
- DK1358159T3 DK1358159T3 DK02701374T DK02701374T DK1358159T3 DK 1358159 T3 DK1358159 T3 DK 1358159T3 DK 02701374 T DK02701374 T DK 02701374T DK 02701374 T DK02701374 T DK 02701374T DK 1358159 T3 DK1358159 T3 DK 1358159T3
- Authority
- DK
- Denmark
- Prior art keywords
- phosphate
- pharmaceutical compositions
- diaminopyridine
- tartrate
- diaminopyridine tartrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0101495A FR2820423B1 (fr) | 2001-02-05 | 2001-02-05 | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations |
PCT/FR2002/000387 WO2002062760A1 (fr) | 2001-02-05 | 2002-02-01 | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1358159T3 true DK1358159T3 (da) | 2009-11-23 |
Family
ID=8859598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02701374T DK1358159T3 (da) | 2001-02-05 | 2002-02-01 | 3,4-diaminopyridintartrat og phosphat, farmaceutiske præparater og anvendelser deraf |
Country Status (9)
Country | Link |
---|---|
US (3) | US20040106651A1 (da) |
EP (1) | EP1358159B1 (da) |
CY (1) | CY1109496T1 (da) |
DE (1) | DE60233030D1 (da) |
DK (1) | DK1358159T3 (da) |
ES (1) | ES2330725T3 (da) |
FR (1) | FR2820423B1 (da) |
PT (1) | PT1358159E (da) |
WO (1) | WO2002062760A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2840591A1 (en) | 2011-06-30 | 2013-01-03 | Biomarin Pharmaceuticals, Inc. | Methods of administering 3,4-diaminopyridine |
EP3412656A1 (en) | 2017-06-08 | 2018-12-12 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Crystalline forms of amifampridine dihydrochloride |
EP3696169B1 (en) | 2019-04-18 | 2023-01-11 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Manufacturing process for amifampridine phosphate |
JP2022542659A (ja) * | 2019-08-06 | 2022-10-06 | カタリスト ファーマシューティカルズ, インコーポレイテッド | 性機能不全を処置するための方法 |
WO2023023463A1 (en) * | 2021-08-19 | 2023-02-23 | Catalyst Pharmaceuticals, Inc. | Method for treating botulinum toxin poisoning |
CN114712321B (zh) * | 2022-04-22 | 2024-05-24 | 河北一品生物医药有限公司 | 磷酸二氨基吡啶缓释片及其制备方法 |
DE102022126035A1 (de) | 2022-10-07 | 2024-04-18 | Thomas Böhmeke | Verwendung von Aminopyridin bei der Behandlung einer Fatigue |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386095A (en) * | 1982-02-22 | 1983-05-31 | Cornell Research Foundation, Inc. | Diaminopyridines to improve cognition |
IL74373A0 (en) * | 1984-02-21 | 1985-05-31 | Lilly Co Eli | Process for the preparation of diaminopyridines |
US4562196A (en) * | 1984-04-06 | 1985-12-31 | Nelson Research & Development | 2,4-Diaminopyridine as a pharmacologic agent |
IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
US5952357A (en) * | 1993-12-23 | 1999-09-14 | Cornell Research Foundation, Inc. | Treating diseases of the anterior horn cells |
SE9504537D0 (sv) * | 1995-12-19 | 1995-12-19 | Jan Hedner | Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet |
US5721215A (en) * | 1996-03-20 | 1998-02-24 | Allergan | Injectable therapy for control of muscle spasms and pain related to muscle spasms |
AU3360000A (en) * | 1999-02-09 | 2000-08-29 | Uab Research Foundation | Use of 4-amino pyridine for treatment of peripheral neuropathies |
-
2001
- 2001-02-05 FR FR0101495A patent/FR2820423B1/fr not_active Expired - Lifetime
-
2002
- 2002-02-01 EP EP02701374A patent/EP1358159B1/fr not_active Expired - Lifetime
- 2002-02-01 DK DK02701374T patent/DK1358159T3/da active
- 2002-02-01 ES ES02701374T patent/ES2330725T3/es not_active Expired - Lifetime
- 2002-02-01 US US10/467,082 patent/US20040106651A1/en not_active Abandoned
- 2002-02-01 DE DE60233030T patent/DE60233030D1/de not_active Expired - Lifetime
- 2002-02-01 PT PT02701374T patent/PT1358159E/pt unknown
- 2002-02-01 WO PCT/FR2002/000387 patent/WO2002062760A1/fr active Application Filing
-
2009
- 2009-10-20 CY CY20091101085T patent/CY1109496T1/el unknown
-
2013
- 2013-11-20 US US14/085,017 patent/US20140080875A1/en not_active Abandoned
-
2015
- 2015-08-05 US US14/818,848 patent/US20150353467A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60233030D1 (de) | 2009-09-03 |
WO2002062760A1 (fr) | 2002-08-15 |
PT1358159E (pt) | 2009-10-27 |
US20040106651A1 (en) | 2004-06-03 |
FR2820423B1 (fr) | 2005-12-02 |
EP1358159B1 (fr) | 2009-07-22 |
EP1358159A1 (fr) | 2003-11-05 |
FR2820423A1 (fr) | 2002-08-09 |
US20140080875A1 (en) | 2014-03-20 |
ES2330725T3 (es) | 2009-12-15 |
CY1109496T1 (el) | 2014-08-13 |
US20150353467A1 (en) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300370A (et) | Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat | |
NO20033384D0 (no) | Farmasöytisk formulering | |
EE200300369A (et) | Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat | |
HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
NO20033785D0 (no) | Farmasöytisk formulering | |
GB0118689D0 (en) | Pharmaceutical formulation | |
HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
NO20035627D0 (no) | Farmasöytisk formulering | |
HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
DK1358159T3 (da) | 3,4-diaminopyridintartrat og phosphat, farmaceutiske præparater og anvendelser deraf | |
DK1275647T3 (da) | Octahydro-1H-pyrido[1,2-a]pyrazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
IL160960A0 (en) | Reduced toxicity cisplatin formulations and methods for using the same | |
MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. | |
GB0104749D0 (en) | Pharmaceutical formulation | |
NO20041236L (no) | Farmasoytisk formulering | |
NO20040408L (no) | Fast frittflytende fosfatblanding og andvendelse derav. | |
SE0102957D0 (sv) | Pharmaceutical formulation | |
SE0101171D0 (sv) | Pharmaceutical formulation | |
SE0101325D0 (sv) | Pharmaceutical formulation | |
SE0101326D0 (sv) | Pharmaceutical formulation | |
SE0102572D0 (sv) | Pharmaceutical formulation | |
SE0103565D0 (sv) | Pharmaceutical formulation |